Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Logan Kshatriya
Renal Cell Carcinoma is a common form of kidney cancer that traditionally required radical nephrectomy, the complete removal of the affected kidney. However, recent advancements in medical science and surgical techniques have paved the way for renal preservation therapy, also known as nephron-sparing surgery or partial nephrectomy. This revolutionary approach aims to preserve kidney function while effectively treating the cancer. This article provides an overview of renal preservation therapy, highlighting its advantages such as kidney function preservation, minimized surgical complications, enhanced oncological outcomes, and expanded future treatment options. The various surgical techniques and advancements in imaging technology are discussed, along with considerations for patient selection. Renal preservation therapy represents a significant breakthrough in RCC treatment, offering improved quality of life and reduced long-term complications for patients.